GNCA
Genocea Biosciences, Inc.
GNCA
GNCA
Delisted
GNCA was delisted on the 2nd of June, 2022.
31 hedge funds and large institutions have $108M invested in Genocea Biosciences, Inc. in 2014 Q1 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
+31
Holders Change %
–
% of All Funds
0.9%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
31
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$30.4M |
| 2 |
DM
Deerfield Management
New York
|
$12M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
$6.71M |
| 4 |
Jennison Associates
New York
|
$3.64M |
| 5 |
Axa
Paris,
France
|
$3.03M |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NFA
26
Nationwide Fund Advisors
Columbus,
Ohio
| $22K | +$22K | +150 | New |
|
|
BA
27
BlackRock Advisors
Wilmington,
Delaware
| $21K | +$21K | +144 | New |
|
28
Bank of America
Charlotte,
North Carolina
| $16K | +$16K | +113 | New |
|
|
TRCT
29
Tower Research Capital (TRC)
New York
| $12K | +$12K | +84 | New |
|
30
Barclays
London,
United Kingdom
| $2K | +$2K | +13 | New |
|